Search Result "parp-1"
Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 1 Year: 2006 Page: 39-53
Author(s): Victoria Cepeda, Miguel A. Fuertes, Josefina Castilla, Carlos Alonso, Celia Quevedo, Manual Soto, Jose M. Perez
Methods of PARP-1 Determination and its Importance in LivingOrganisms
Journal: Protein & Peptide Letters
Volume: 29 Issue: 6 Year: 2022 Page: 496-504
Author(s):
Recent Progress in the Research on Benzimidazole PARP-1 Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 19 Year: 2022 Page: 2438-2462
Author(s):
Synthetic PARP-1 Inhibitors Reported During the Last Decade
Journal: Letters in Drug Design & Discovery
Volume: 20 Issue: 7 Year: 2023 Page: 793-807
Author(s):
Synthesis and In silico Studies of Quinazolinone Derivatives as PARP-1 Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 17 Issue: 12 Year: 2020 Page: 1552-1565
Author(s): Sonia Verma,Akashdeep Singh Pathania,Somesh Baranwal,Pradeep Kumar
Synthesis and In Silico Studies of Quinazolinones as PARP-1 Inhibitors
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 27 Issue: 9 Year: 2024 Page: 1329-1343
Author(s): Ankit Kumar Singh
Modulation of Transcription by PARP-1: Consequences in Carcinogenesis and Inflammation
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2007 Page: 1179-1187
Author(s): R. Aguilar-Quesada, J. A. Munoz-Gamez, D. Martin-Oliva, A. Peralta-Leal, R. Quiles-Perez, J. M. Rodriguez-Vargas, M. Ruiz de Almodovar, C. Conde, A. Ruiz-Extremera, F. J. Oliver
The Genetic Regulation of ADPRT/PARP-1 in Aging and Cancer Susceptibility
Journal: Current Pharmacogenomics
Volume: 3 Issue: 1 Year: 2005 Page: 9-19
Author(s): Kristin L. Lockett, Isaac V. Snowhite, Jennifer J. Hu
Oxidative DNA Damage-induced PARP-1-mediated Autophagic FluxDisruption Contributes to Bupivacaine-induced Neurotoxicity DuringPregnancy
Journal: Current Neuropharmacology
Volume: 21 Issue: 10 Year: 2023 Page: 2134-2150
Author(s):
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 4 Year: 2010 Page: 368-383
Author(s): L. Tentori, A. Muzi, A.S. Dorio, M. Scarsella, C. Leonetti, G.M. Shah, W. Xu, E. Camaioni, B. Gold, R. Pellicciari, F. Dantzer, J. Zhang, G. Graziani